Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ETI
Enviroleach Technologies
$0.00
$0.00
$0.00
N/AN/AN/A17,860 shs
First Trust Preferred Securities and Income ETF stock logo
FPE
First Trust Preferred Securities and Income ETF
$17.03
-0.1%
$17.21
$15.45
$17.45
$5.22B0.271.42 million shs679,938 shs
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
$38.57
+0.3%
$39.84
$29.85
$45.00
$4.90B1.251.23 million shs547,082 shs
Linde AG stock logo
LNAGF
Linde
$218.00
$218.00
$194.75
$227.88
N/AN/A136 shsN/A
Solvay SA stock logo
SVYSF
Solvay
$33.00
+1.4%
$27.69
$22.35
$122.42
N/AN/A7,951 shs10,267 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ETI
Enviroleach Technologies
0.00%0.00%0.00%0.00%0.00%
First Trust Preferred Securities and Income ETF stock logo
FPE
First Trust Preferred Securities and Income ETF
-0.12%+0.09%-1.87%-0.35%+7.38%
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
-1.69%+1.72%-4.04%+12.42%+17.04%
Linde AG stock logo
LNAGF
Linde
0.00%0.00%0.00%0.00%0.00%
Solvay SA stock logo
SVYSF
Solvay
-2.57%-0.94%+28.87%+19.85%-71.72%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ETI
Enviroleach Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
First Trust Preferred Securities and Income ETF stock logo
FPE
First Trust Preferred Securities and Income ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
4.8865 of 5 stars
3.41.00.04.42.82.54.4
Linde AG stock logo
LNAGF
Linde
N/AN/AN/AN/AN/AN/AN/AN/A
Solvay SA stock logo
SVYSF
Solvay
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ETI
Enviroleach Technologies
N/AN/AN/AN/A
First Trust Preferred Securities and Income ETF stock logo
FPE
First Trust Preferred Securities and Income ETF
0.00
N/AN/AN/A
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
2.86
Moderate Buy$53.2938.15% Upside
Linde AG stock logo
LNAGF
Linde
N/AN/AN/AN/A
Solvay SA stock logo
SVYSF
Solvay
N/AN/AN/AN/A

Current Analyst Ratings

Latest SVYSF, ETI, FPE, HALO, and LNAGF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/17/2024
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$50.00
4/16/2024
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$50.00
2/29/2024
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$54.00
2/21/2024
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$72.00
2/21/2024
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$48.00 ➝ $50.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ETI
Enviroleach Technologies
N/AN/AN/AN/AN/AN/A
First Trust Preferred Securities and Income ETF stock logo
FPE
First Trust Preferred Securities and Income ETF
N/AN/AN/AN/AN/AN/A
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
$829.25M5.91$3.13 per share12.31$0.63 per share61.22
Linde AG stock logo
LNAGF
Linde
N/AN/AN/AN/AN/AN/A
Solvay SA stock logo
SVYSF
Solvay
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ETI
Enviroleach Technologies
N/AN/A0.00N/AN/AN/AN/AN/AN/A
First Trust Preferred Securities and Income ETF stock logo
FPE
First Trust Preferred Securities and Income ETF
N/AN/A0.00N/AN/AN/AN/AN/A
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
$281.59M$2.1118.289.030.4533.96%248.20%19.13%5/7/2024 (Confirmed)
Linde AG stock logo
LNAGF
Linde
N/AN/A0.00N/AN/AN/AN/AN/A
Solvay SA stock logo
SVYSF
Solvay
N/A-$1.24N/AN/AN/AN/AN/AN/A

Latest SVYSF, ETI, FPE, HALO, and LNAGF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
$0.64N/A-$0.64N/AN/AN/A  
2/20/2024Q4 2023
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
$0.77$0.75-$0.02$0.85$235.25 million$230.04 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ETI
Enviroleach Technologies
N/AN/AN/AN/AN/A
First Trust Preferred Securities and Income ETF stock logo
FPE
First Trust Preferred Securities and Income ETF
$0.965.64%N/AN/AN/A
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
N/AN/AN/AN/AN/A
Linde AG stock logo
LNAGF
Linde
N/AN/AN/AN/AN/A
Solvay SA stock logo
SVYSF
Solvay
$2.407.27%N/AN/A N/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ETI
Enviroleach Technologies
N/AN/AN/A
First Trust Preferred Securities and Income ETF stock logo
FPE
First Trust Preferred Securities and Income ETF
N/AN/AN/A
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
17.89
6.64
5.50
Linde AG stock logo
LNAGF
Linde
N/AN/AN/A
Solvay SA stock logo
SVYSF
Solvay
N/AN/AN/A

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
ETI
Enviroleach Technologies
147,000N/AN/ANot Optionable
First Trust Preferred Securities and Income ETF stock logo
FPE
First Trust Preferred Securities and Income ETF
N/A306.76 millionN/ANot Optionable
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
373127.05 million124.01 millionOptionable
Linde AG stock logo
LNAGF
Linde
55,646N/AN/ANot Optionable
Solvay SA stock logo
SVYSF
Solvay
9,000N/AN/ANot Optionable

SVYSF, ETI, FPE, HALO, and LNAGF Headlines

SourceHeadline
Solvay fourth quarter and full-year 2023 resultsSolvay fourth quarter and full-year 2023 results
finance.yahoo.com - March 13 at 8:23 AM
Solvay reports Q4 resultsSolvay reports Q4 results
msn.com - March 13 at 8:23 AM
Solvay 2024 Financial CalendarSolvay 2024 Financial Calendar
finance.yahoo.com - December 20 at 3:40 AM
Syensqo successfully launched on EuronextSyensqo successfully launched on Euronext
finance.yahoo.com - December 11 at 8:17 AM
Solvay announces the publication of a supplement to its information documentSolvay announces the publication of a supplement to its information document
finance.yahoo.com - November 20 at 8:18 AM
Syensqo launches its 5-year growth strategy to create significant valueSyensqo launches its 5-year growth strategy to create significant value
finance.yahoo.com - November 13 at 7:30 AM
Solvay (EssentialCo) unveils its new strategy and 2028 financial targetsSolvay (EssentialCo) unveils its new strategy and 2028 financial targets
finance.yahoo.com - November 13 at 1:18 AM
Solvay announces the future board of directors for new standalone company SYENSQOSolvay announces the future board of directors for new standalone company SYENSQO
finance.yahoo.com - November 3 at 10:44 AM
Solvay invites analysts and institutional investors to SpecialtyCo’s and EssentialCo’s first Capital Markets DaySolvay invites analysts and institutional investors to SpecialtyCo’s and EssentialCo’s first Capital Markets Day
finance.yahoo.com - September 29 at 7:04 AM
Solvay Launches PPA Grades to Support Sustainable Innovation in E-MobilitySolvay Launches PPA Grades to Support Sustainable Innovation in E-Mobility
plasticstoday.com - September 19 at 6:37 PM
Solvay, NY Air Quality & PollenSolvay, NY Air Quality & Pollen
wunderground.com - September 5 at 11:15 PM
SOBS Solvay Bank Corp.SOBS Solvay Bank Corp.
seekingalpha.com - August 26 at 3:31 PM
Solvay reports Q2 resultsSolvay reports Q2 results
msn.com - August 4 at 6:46 AM
Solvay Union Free School DistrictSolvay Union Free School District
usnews.com - May 23 at 1:49 PM
Solvay sells PP compounding business to BasellSolvay sells PP compounding business to Basell
plasticstoday.com - May 10 at 5:21 PM
Solvay establishes synthetic biology hub in the USSolvay establishes synthetic biology hub in the US
cen.acs.org - April 9 at 1:23 PM
Solvay SA (SVYSF) Stock Historical Prices & Data - Yahoo FinanceSolvay SA (SVYSF) Stock Historical Prices & Data - Yahoo Finance
finance.yahoo.com - March 30 at 2:23 PM
Solvay, United States - Weather Forecasts | Maps | News - Yahoo WeatherSolvay, United States - Weather Forecasts | Maps | News - Yahoo Weather
yahoo.com - January 14 at 12:16 AM
European Stocks Propelled Higher by Strong EarningsEuropean Stocks Propelled Higher by Strong Earnings
thestreet.com - December 28 at 3:04 PM
Bankers, Bosses Doing Macron Few Favors by Pointing Out Le Pens FlawsBankers, Bosses Doing Macron Few Favors by Pointing Out Le Pen's Flaws
thestreet.com - December 26 at 2:32 PM
Seasonal Influenza Vaccines World Market Size is Expected to Reach Around USD 5.7 billion by 2025 | CAGR 7.1%Seasonal Influenza Vaccines World Market Size is Expected to Reach Around USD 5.7 billion by 2025 | CAGR 7.1%
pharmiweb.com - November 22 at 6:24 PM
Solvay, NY Weather ConditionsSolvay, NY Weather Conditions
wunderground.com - October 30 at 7:25 PM
Solvay High SchoolSolvay High School
usnews.com - October 13 at 5:53 PM
Solvay SA (SVYSF) CEO Ilham Kadri on Q2 2022 Results - Earnings Call TranscriptSolvay SA (SVYSF) CEO Ilham Kadri on Q2 2022 Results - Earnings Call Transcript
seekingalpha.com - July 30 at 7:09 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Enviroleach Technologies

CNSX:ETI
EnviroMetal Technologies Inc. develops and markets technologies for the extraction of precious and other valuable metals from the mine products and electronic waste in the primary and secondary metal sectors. The company's technologies are used in the electronic waste processing industry to recover gold and other valuable metals from PCBA; and the mining industry for the recovery of gold from of ores and concentrates. It also operates E-waste and mineral processing facility. The company was formerly known as EnviroLeach Technologies Inc. and changed its name to EnviroMetal Technologies Inc. in August 2021. EnviroMetal Technologies Inc. was incorporated in 2016 and is headquartered in Burnaby, Canada.
First Trust Preferred Securities and Income ETF logo

First Trust Preferred Securities and Income ETF

NYSEARCA:FPE
The First Trust Preferred Securities and Income ETF (FPE) is an exchange-traded fund that mostly invests in broad credit fixed income. The fund is an actively managed fund that attempts to generate income by investing globally in preferred equities and income producing debt across the market cap spectrum. FPE was launched on Feb 12, 2013 and is managed by First Trust.
Halozyme Therapeutics logo

Halozyme Therapeutics

NASDAQ:HALO
Halozyme Therapeutics, Inc., a biopharma technology platform company, researches, develops, and commercializes proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally. The company's products are based on the patented recombinant human hyaluronidase enzyme (rHuPH20) that enables delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. It offers Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous (SC) fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in SC urography and to enhance resorption of radiopaque agents; rilpivirine, cabotegravir, and N6LS BNAB for the treatment of HIV; ocrelizumab for multiple sclerosis; XYOSTED, an injection for SC administration of testosterone replacement therapy; and ATRS-1902, a proprietary drug device combination product. The company also provides Herceptin (trastuzumab), Herceptin Hylecta, and Phesgo to treat breast cancer; Mabthera SC for the treatment of chronic lymphocytic leukemia; HYQVIA to treat primary immunodeficiency disorders; and DARZALEX for patients with amyloidosis, smoldering myeloma, and multiple myeloma. In addition, it offers Epinephrine Injection to treat allergic reactions; nivolumab+relatlimab and ANTI-TIM3 for the treatment of solid tumors; ARGX-117 for multifocal motor neuropathy; atezolizumab; nivolumab; afgartigimod; teriparatide injections; and OTREXUP, a SC methotrexate injection for adults with severe active rheumatoid arthritis and severe recalcitrant psoriasis, as well as children with active polyarticular juvenile idiopathic arthritis. Further, the company provides ATRS-1902 for adrenal crisis rescue; ARGX-113; and ARGX-117 to treat severe autoimmune diseases in multifocal motor neuropathy. Halozyme Therapeutics, Inc. was founded in 1998 and is headquartered in San Diego, California.
Linde logo

Linde

OTCMKTS:LNAGF
Linde Aktiengesellschaft operates as a gases and engineering company worldwide. It operates in two divisions, Gases and Engineering. The Gases division produces and distributes atmospheric gases oxygen, nitrogen, and argon; and hydrogen, acetylene, carbon monoxide, carbon dioxide, shielding gases, noble gases, and high-purity specialty gases for use in industry, commerce, science, and research sectors, as well as develops and distributes procedures and systems for gas applications. This division also offers pharmaceutical and medical gases and services to the healthcare industry; and support services, technical equipment, and safety products, as well as develops hydrogen technology. The Engineering division provides planning, project development, and construction services with a focus on market segments, such as olefin, natural gas, air separation, and hydrogen and synthesis gas plants. This division's plants are used in various fields, including the petrochemical and chemical industries; in refineries and fertilizer plants; to recover air gases; to produce hydrogen and synthesis gases; to treat natural gas; and to produce noble gases. Linde Aktiengesellschaft is headquartered in Munich, Germany. As of October 31, 2018, Linde Aktiengesellschaft operates as a subsidiary of Linde plc.
Solvay logo

Solvay

OTCMKTS:SVYSF
Solvay SA provides advanced materials and specialty chemicals worldwide. It operates through four segments: Materials, Chemicals, Solutions, and Corporate & Business Services. The Materials segment offers specialty polymers, including aromatic polymers, high barrier polymers, and fluoropolymers for the electronics, automotive, aerospace, and healthcare industries; and composite materials for aerospace engineered materials market. The Chemicals segment produces and sells soda ash and sodium bicarbonate primarily to the flat and container glass industries, as well as for use in detergents, pharmaceutical, and feed and food industries; hydrogen peroxide for use primarily in the paper industry to bleach pulp, as well as chemicals, electronics, food, mining, and environment; and dispersible silica for tire manufacturers; and solvent solutions, phenols and derivatives, polyamide derivatives and smart, functional, and sustainable yarns and polymers. The Solutions segment offers specialty chemicals for agro, home and personal care, coatings, and industrial markets; technology solutions in specialty mining reagents, phosphine-based chemistry, and solutions for the stabilization of polymers; fluorine and rare-earth formulations for automotive, electronics, agrochemical, and construction applications; and vanillin for the food, flavors, and fragrances industries, as well as value-added intermediates used in monomers and polymers, pharmaceuticals, agrochemicals, and electronics. This segment also provides various products for upstream oilfield chemicals sector, as well as sodium hypophosphite for metal plating and other applications; and PROBAN, a technological process that offers durable flame retardant properties to cotton-based textiles. The Corporate & Business Services segment provides energy and other business services. The company was founded in 1863 and is headquartered in Brussels, Belgium.